Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Combination Vaccines Market Report 2016

  • QYR673161
  • 117 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Combination Vaccines

Revenue, means the sales value of Combination Vaccines

This report studies sales (consumption) of Combination Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

ALK - Abello A/S (Denmark)

Altimmune, Inc. (US)

Bavarian Nordic A/S (Denmark)

BiondVax Pharmaceuticals Ltd. (Israel)

Bharat Biotech International Limited (India)

GlaxoSmithKline Plc. (UK)

Hualan Biological Engineering Inc. (China)

Janssen Pharmaceuticals, Inc. (US)

MedImmune (US)

Merck & Co., Inc. (US)

Pfizer Inc. (US)

Sanofi Pasteur SA (France)

Serum Institute of India Pvt. Ltd. (India)

Shanghai BravoBio Co., Ltd. (China)

Seqirus (UK)

SK Chemicals Co., Ltd. (Korea)

Takeda Pharmaceutical Company Limited (Japan)

Zydus Cadila (India)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Combination Vaccines in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Combination Vaccines Market Report 2016

1 Combination Vaccines Overview

1.1 Product Overview and Scope of Combination Vaccines

1.2 Classification of Combination Vaccines

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Combination Vaccines

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Combination Vaccines (2011-2021)

1.4.1 USA Combination Vaccines Sales and Growth Rate (2011-2021)

1.4.2 USA Combination Vaccines Revenue and Growth Rate (2011-2021)

2 USA Combination Vaccines Competition by Manufacturers

2.1 USA Combination Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Combination Vaccines Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Combination Vaccines Average Price by Manufactures (2015 and 2016)

2.4 Combination Vaccines Market Competitive Situation and Trends

2.4.1 Combination Vaccines Market Concentration Rate

2.4.2 Combination Vaccines Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Combination Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Combination Vaccines Sales and Market Share by Type (2011-2016)

3.2 USA Combination Vaccines Revenue and Market Share by Type (2011-2016)

3.3 USA Combination Vaccines Price by Type (2011-2016)

3.4 USA Combination Vaccines Sales Growth Rate by Type (2011-2016)

4 USA Combination Vaccines Sales (Volume) by Application (2011-2016)

4.1 USA Combination Vaccines Sales and Market Share by Application (2011-2016)

4.2 USA Combination Vaccines Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Combination Vaccines Manufacturers Profiles/Analysis

5.1 ALK - Abello A/S (Denmark)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Combination Vaccines Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 ALK - Abello A/S (Denmark) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Altimmune, Inc. (US)

5.2.2 Combination Vaccines Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Altimmune, Inc. (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Bavarian Nordic A/S (Denmark)

5.3.2 Combination Vaccines Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Bavarian Nordic A/S (Denmark) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 BiondVax Pharmaceuticals Ltd. (Israel)

5.4.2 Combination Vaccines Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 BiondVax Pharmaceuticals Ltd. (Israel) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Bharat Biotech International Limited (India)

5.5.2 Combination Vaccines Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Bharat Biotech International Limited (India) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 GlaxoSmithKline Plc. (UK)

5.6.2 Combination Vaccines Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 GlaxoSmithKline Plc. (UK) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Hualan Biological Engineering Inc. (China)

5.7.2 Combination Vaccines Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Hualan Biological Engineering Inc. (China) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Janssen Pharmaceuticals, Inc. (US)

5.8.2 Combination Vaccines Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Janssen Pharmaceuticals, Inc. (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 MedImmune (US)

5.9.2 Combination Vaccines Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 MedImmune (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Merck & Co., Inc. (US)

5.10.2 Combination Vaccines Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Merck & Co., Inc. (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Pfizer Inc. (US)

5.12 Sanofi Pasteur SA (France)

5.13 Serum Institute of India Pvt. Ltd. (India)

5.14 Shanghai BravoBio Co., Ltd. (China)

5.15 Seqirus (UK)

5.16 SK Chemicals Co., Ltd. (Korea)

5.17 Takeda Pharmaceutical Company Limited (Japan)

5.18 Zydus Cadila (India)

6 Combination Vaccines Manufacturing Cost Analysis

6.1 Combination Vaccines Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Combination Vaccines

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Combination Vaccines Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Combination Vaccines Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Combination Vaccines Market Forecast (2016-2021)

10.1 USA Combination Vaccines Sales, Revenue Forecast (2016-2021)

10.2 USA Combination Vaccines Sales Forecast by Type (2016-2021)

10.3 USA Combination Vaccines Sales Forecast by Application (2016-2021)

10.4 Combination Vaccines Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Combination Vaccines

Table Classification of Combination Vaccines

Figure USA Sales Market Share of Combination Vaccines by Type in 2015

Table Application of Combination Vaccines

Figure USA Sales Market Share of Combination Vaccines by Application in 2015

Figure USA Combination Vaccines Sales and Growth Rate (2011-2021)

Figure USA Combination Vaccines Revenue and Growth Rate (2011-2021)

Table USA Combination Vaccines Sales of Key Manufacturers (2015 and 2016)

Table USA Combination Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Combination Vaccines Sales Share by Manufacturers

Figure 2016 Combination Vaccines Sales Share by Manufacturers

Table USA Combination Vaccines Revenue by Manufacturers (2015 and 2016)

Table USA Combination Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Combination Vaccines Revenue Share by Manufacturers

Table 2016 USA Combination Vaccines Revenue Share by Manufacturers

Table USA Market Combination Vaccines Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Combination Vaccines Average Price of Key Manufacturers in 2015

Figure Combination Vaccines Market Share of Top 3 Manufacturers

Figure Combination Vaccines Market Share of Top 5 Manufacturers

Table USA Combination Vaccines Sales by Type (2011-2016)

Table USA Combination Vaccines Sales Share by Type (2011-2016)

Figure USA Combination Vaccines Sales Market Share by Type in 2015

Table USA Combination Vaccines Revenue and Market Share by Type (2011-2016)

Table USA Combination Vaccines Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Combination Vaccines by Type (2011-2016)

Table USA Combination Vaccines Price by Type (2011-2016)

Figure USA Combination Vaccines Sales Growth Rate by Type (2011-2016)

Table USA Combination Vaccines Sales by Application (2011-2016)

Table USA Combination Vaccines Sales Market Share by Application (2011-2016)

Figure USA Combination Vaccines Sales Market Share by Application in 2015

Table USA Combination Vaccines Sales Growth Rate by Application (2011-2016)

Figure USA Combination Vaccines Sales Growth Rate by Application (2011-2016)

Table ALK - Abello A/S (Denmark) Basic Information List

Table ALK - Abello A/S (Denmark) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ALK - Abello A/S (Denmark) Combination Vaccines Sales Market Share (2011-2016)

Table Altimmune, Inc. (US) Basic Information List

Table Altimmune, Inc. (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Altimmune, Inc. (US) Combination Vaccines Sales Market Share (2011-2016)

Table Bavarian Nordic A/S (Denmark) Basic Information List

Table Bavarian Nordic A/S (Denmark) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bavarian Nordic A/S (Denmark) Combination Vaccines Sales Market Share (2011-2016)

Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information List

Table BiondVax Pharmaceuticals Ltd. (Israel) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table BiondVax Pharmaceuticals Ltd. (Israel) Combination Vaccines Sales Market Share (2011-2016)

Table Bharat Biotech International Limited (India) Basic Information List

Table Bharat Biotech International Limited (India) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bharat Biotech International Limited (India) Combination Vaccines Sales Market Share (2011-2016)

Table GlaxoSmithKline Plc. (UK) Basic Information List

Table GlaxoSmithKline Plc. (UK) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Plc. (UK) Combination Vaccines Sales Market Share (2011-2016)

Table Hualan Biological Engineering Inc. (China) Basic Information List

Table Hualan Biological Engineering Inc. (China) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hualan Biological Engineering Inc. (China) Combination Vaccines Sales Market Share (2011-2016)

Table Janssen Pharmaceuticals, Inc. (US) Basic Information List

Table Janssen Pharmaceuticals, Inc. (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Pharmaceuticals, Inc. (US) Combination Vaccines Sales Market Share (2011-2016)

Table MedImmune (US) Basic Information List

Table MedImmune (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table MedImmune (US) Combination Vaccines Sales Market Share (2011-2016)

Table Merck & Co., Inc. (US) Basic Information List

Table Merck & Co., Inc. (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co., Inc. (US) Combination Vaccines Sales Market Share (2011-2016)

Table Pfizer Inc. (US) Basic Information List

Table Pfizer Inc. (US) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Inc. (US) Combination Vaccines Sales Market Share (2011-2016)

Table Sanofi Pasteur SA (France) Basic Information List

Table Sanofi Pasteur SA (France) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Pasteur SA (France) Combination Vaccines Sales Market Share (2011-2016)

Table Serum Institute of India Pvt. Ltd. (India) Basic Information List

Table Serum Institute of India Pvt. Ltd. (India) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Serum Institute of India Pvt. Ltd. (India) Combination Vaccines Sales Market Share (2011-2016)

Table Shanghai BravoBio Co., Ltd. (China) Basic Information List

Table Shanghai BravoBio Co., Ltd. (China) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shanghai BravoBio Co., Ltd. (China) Combination Vaccines Sales Market Share (2011-2016)

Table Seqirus (UK) Basic Information List

Table Seqirus (UK) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Seqirus (UK) Combination Vaccines Sales Market Share (2011-2016)

Table SK Chemicals Co., Ltd. (Korea) Basic Information List

Table SK Chemicals Co., Ltd. (Korea) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table SK Chemicals Co., Ltd. (Korea) Combination Vaccines Sales Market Share (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List

Table Takeda Pharmaceutical Company Limited (Japan) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Combination Vaccines Sales Market Share (2011-2016)

Table Zydus Cadila (India) Basic Information List

Table Zydus Cadila (India) Combination Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Zydus Cadila (India) Combination Vaccines Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Combination Vaccines

Figure Manufacturing Process Analysis of Combination Vaccines

Figure Combination Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Combination Vaccines Major Manufacturers in 2015

Table Major Buyers of Combination Vaccines

Table Distributors/Traders List

Figure USA Combination Vaccines Production and Growth Rate Forecast (2016-2021)

Figure USA Combination Vaccines Revenue and Growth Rate Forecast (2016-2021)

Table USA Combination Vaccines Production Forecast by Type (2016-2021)

Table USA Combination Vaccines Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390